Bim has emerged as a key pro-apoptotic protein in the initiation of the intrinsic apoptotic pathway under many conditions, including treatment of AML cells with therapeutic agents (eg [32–37]). This evidence concerns the gene BCL2L11 and acute myeloid leukemia.